PRKCA and breast cancer: Notwithstanding the rather complex and incompletely understood expression patterns and isozyme activities, evidence arose that above all the canonical PKCα has pro-survival, pro-proliferative, and pro-migration activity of BC cells in-vitro and independently predicts a poor 10 years outcome of BC disease [2].